Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

morgan-stanley-initiates-novagold-stock-coverage-at-overweight,-$13.80-target

Morgan Stanley initiates NovaGold stock coverage at overweight, $13.80 target

Apr 9, 2026

Morgan Stanley initiates NovaGold stock coverage at overweight, $13.80 target

Read more
craig-hallum-maintains-buy-on-xtant-medical-holdings,-inc.-(xtnt)-march-2026

Craig-Hallum Maintains Buy on Xtant Medical Holdings, Inc. (XTNT) March 2026

Apr 9, 2026

Craig-Hallum maintained its Buy rating on Xtant Medical Holdings, Inc. (XTNT) on March 18, 2026, citing expected EBITDA…

Read more
maintained-buy:-jefferies-and-johnson-rice-on-protagonist-therapeutics-(ptgx)-march-2026

Maintained Buy: Jefferies and Johnson Rice on Protagonist Therapeutics (PTGX) March 2026

Apr 9, 2026

Jefferies and Johnson Rice both maintained Buy ratings on Protagonist Therapeutics, Inc. (PTGX) on March 18, 2026, marking…

Read more
coeur-mining-shares-rise-3.5%-on-analyst-optimism

Coeur Mining Shares Rise 3.5% on Analyst Optimism

Apr 9, 2026

Got story updates? Submit your updates here. › Coeur Mining’s mining equipment and infrastructure reflect the company’s industrial…

Read more
the-bull-case-for-umb-financial-(umbf)-could-change-following-heartland-integration-progress-and-new-analyst-coverage

The Bull Case For UMB Financial (UMBF) Could Change Following Heartland Integration Progress And New Analyst Coverage

Apr 9, 2026

UMB Financial Corporation recently filed an $18.344 million shelf registration for 160,000 common shares linked to its employee…

Read more
morgan-stanley-maintains-mixed-rating-for-las-vegas-sands-corp.-(lvs)-apr-2026

Morgan Stanley Maintains Mixed Rating for Las Vegas Sands Corp. (LVS) Apr 2026

Apr 9, 2026

On April 08, 2026 Morgan Stanley maintained a mixed LVS analyst rating for Las Vegas Sands Corp. and…

Read more
morgan-stanley-maintains-underweight-on-mgm-resorts-international-april-2026

Morgan Stanley Maintains Underweight on MGM Resorts International April 2026

Apr 9, 2026

On April 08, 2026 Morgan Stanley maintained an Underweight MGM analyst rating for MGM Resorts International (MGM) and…

Read more
morgan-stanley-maintains-penn-entertainment,-inc.-(penn),-target-$16-april-2026

Morgan Stanley Maintains PENN Entertainment, Inc. (PENN), Target $16 April 2026

Apr 9, 2026

On April 8, 2026 Morgan Stanley maintained its stance on PENN Entertainment, Inc. (PENN) and raised the price…

Read more
morgan-stanley-maintains-mixed-rating-for-srad-sportradar-group-ag-april-2026

Morgan Stanley Maintains Mixed Rating for SRAD Sportradar Group AG April 2026

Apr 8, 2026

Morgan Stanley maintained a mixed rating on Sportradar Group AG (SRAD) on April 08, 2026, making this the…

Read more
craig-hallum-upgrades-aehr-test-systems-(aehr)-to-buy-apr-08-2026

Craig-Hallum upgrades Aehr Test Systems (AEHR) to Buy Apr 08 2026

Apr 8, 2026

Craig-Hallum upgraded Aehr Test Systems (AEHR) from Hold to Buy on April 08, 2026. This AEHR analyst rating…

Read more
citigroup-starts-coverage-of-summit-therapeutics-inc-(smmt),-apr-08-2026,-buy

Citigroup starts coverage of Summit Therapeutics Inc (SMMT), Apr 08 2026, Buy

Apr 8, 2026

Citigroup initiated coverage of Summit Therapeutics Inc. (SMMT) on April 08, 2026 with a Buy rating. This SMMT…

Read more
jpmorgan-earnings-are-imminent;-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call

JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Apr 8, 2026

JPMorgan Chase & Co. (NYSE:JPM) will release earnings for its first quarter before the opening bell on Tuesday,…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. ...
  13. 394
  14. »

Posts pagination

Newer posts Page 1 … Page 8 … Page 394 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.